GSK PLC Toevoegen aan een lijst
|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 1.610,75 GBX | -1,30% |
|
-3,56% | +11,12% |
| 17:24 | Europese aandelen verhandeld in de VS terwijl American Depositary Receipts lager noteren in de handel van dinsdag | MT |
| 11:20 | GSK : JP Morgan handhaaft het verkoopadvies | ZD |
Bedrijfswaardering: GSK plc
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 88.051 | 66.801 | 80.458 | 58.381 | 59.112 | 66.569 | - | - |
| Variatie | - | -24,13% | 20,44% | -27,44% | 1,25% | 12,61% | - | - |
| Bedrijfswaarde 1 | 113.773 | 87.581 | 100.296 | 75.578 | 74.152 | 78.515 | 75.119 | 71.047 |
| Variatie | - | -23,02% | 14,52% | -24,65% | -1,89% | 5,88% | -4,33% | -5,42% |
| K/w-verhouding | 19,2x | 11,8x | 18,6x | 3,93x | 11,9x | 12,8x | 10,4x | 9,38x |
| PBR-ratio | 7,35x | 4,58x | 5,34x | 5,47x | 4,4x | 4,21x | 3,45x | 2,85x |
| PEG | - | 0,5x | -0,8x | 0x | -0,2x | 2,61x | 0,5x | 0,8x |
| Marktkapitalisatie/omzet | 2,61x | 1,96x | 2,36x | 1,99x | 1,95x | 2,1x | 1,99x | 1,88x |
| Bedrijfswaarde/omzet | 3,37x | 2,57x | 2,94x | 2,58x | 2,45x | 2,48x | 2,25x | 2,01x |
| Bedrijfswaarde/EBITDA | 9,51x | 9,19x | 8,85x | 7,23x | 6,37x | 7,36x | 6,43x | 5,57x |
| Bedrijfswaarde/EBIT | 12,7x | 9,83x | 11,4x | 9,27x | 8,44x | 8,51x | 7,45x | 6,35x |
| Bedrijfswaarde/FCF | 22,4x | 16,2x | 22,6x | 12,1x | 13,6x | 14,6x | 10,8x | 9,33x |
| FCF Yield | 4,46% | 6,17% | 4,42% | 8,28% | 7,36% | 6,83% | 9,28% | 10,7% |
| Dividend per aandeel 2 | 1 | 1 | 1 | 0,6125 | 0,58 | 0,6032 | 0,6399 | 0,6807 |
| Rendement | 4,5% | 5,96% | 4,98% | 4,26% | 4% | 3,7% | 3,92% | 4,17% |
| WPA 2 | 1,158 | 1,426 | 1,082 | 3,662 | 1,216 | 1,276 | 1,562 | 1,739 |
| Uitkeringspercentage | 86,4% | 70,1% | 92,4% | 16,7% | 47,7% | 47,3% | 41% | 39,1% |
| Omzet 1 | 33.754 | 34.099 | 34.114 | 29.324 | 30.328 | 31.639 | 33.391 | 35.399 |
| EBITDA 1 | 11.968 | 9.530 | 11.330 | 10.449 | 11.635 | 10.671 | 11.685 | 12.744 |
| EBIT 1 | 8.972 | 8.906 | 8.806 | 8.151 | 8.786 | 9.222 | 10.081 | 11.195 |
| Nettowinst (verlies) 1 | 4.645 | 5.749 | 4.385 | 14.956 | 4.928 | 5.149 | 6.442 | 7.158 |
| Nettoschuld 1 | 25.722 | 20.780 | 19.838 | 17.197 | 15.040 | 11.946 | 8.550 | 4.479 |
| Referentiekoers 2 | 22,24 | 16,78 | 20,08 | 14,38 | 14,50 | 16,32 | 16,32 | 16,32 |
| Aantal aandelen (in duizend) | 3.959.572 | 3.982.185 | 4.006.383 | 4.060.999 | 4.076.145 | 4.078.961 | - | - |
| Datum van publicatie | 05-02-20 | 03-02-21 | 09-02-22 | 01-02-23 | 31-01-24 | - | - | - |
1GBP in Miljoen2GBP
Geschatte gegevens
K/w-verhouding, Gedetailleerde evolutie
Toevoegen aan een lijst 0 geselecteerde | K/w-verhouding | EV/omzet | Beurskap. / EBITDA | Dividendrendement (Y) | Kapi. ($) | |
|---|---|---|---|---|---|---|
| 12.79x | 2.48x | 7.36x | +3.70% | 87,89 mld. | ||
| 59.55x | 18.44x | 44.85x | +0.56% | 832 mld. | ||
| 40.6x | 14.14x | 28.79x | +1.24% | 609 mld. | ||
| 21.38x | 4.62x | 13.07x | +2.80% | 402 mld. | ||
| 38.09x | 7.21x | 15.57x | +3.18% | 346 mld. | ||
| 15.73x | 4.99x | 11.44x | +2.61% | 299 mld. | ||
| 15.84x | 3.75x | 9.69x | +3.73% | 251 mld. | ||
| 28.42x | 5.11x | 15.29x | +1.95% | 246 mld. | ||
| 21.61x | 4.98x | 12.6x | +3.25% | 236 mld. | ||
| 51.65x | 6.94x | 12.15x | +2.74% | 180 mld. | ||
| Gemiddelde | 30,57x | 7,27x | 17,08x | +2,58% | 348,89 mld. | |
| Gewogen gemiddelde per kap. | 36,47x | 9,93x | 23,19x | +2,07% |
